Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zito

Showing results (11-20 of 307) with videos related to

Pageof 31
Sort By:
Public Health|February 24, 2007
Do antidepressants reduce suicide rates?D J Safer, J M Zito
Foot & Ankle|October 1, 1989
Selected measures of ankle dorsiflexion range of motion: differences and intercorrelationsR W Bohannon, D Tiberio, M Zito
Frontiers in Psychiatry|April 2, 2020
Antidepressant Use in Medicaid-Insured Youth: Trends, Covariates, and Future Research NeedsJulie M Zito, Dinci Pennap, Daniel J Safer
The Journal of Orthopaedic and Sports Physical Therapy|October 6, 1997
Lasting effects of one bout of two 15-second passive stretches on ankle dorsiflexion range of motionM Zito, D Driver, C Parker, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2015
Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimensMehmet Burcu, Daniel J Safer, Julie M Zito
DICP : the Annals of Pharmacotherapy|February 1, 1990
Self-reported neuroendocrine effects of antipsychotics in women: a pilot studyJ M Zito, J B Sofair, J Jaeger
Frontiers in Psychiatry|July 1, 2021
Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and CommentaryJulie M Zito, Yue Zhu, Daniel J Safer
The American Journal of Psychiatry|July 1, 1991
New York under the Rivers decision: an epidemiologic study of drug treatment refusalJ M Zito, T J Craig, J Wanderling
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|August 19, 2000
Building pharmacoepidemiological capacity to monitor psychotropic drug use among children enrolled in MedicaidM H Fox, C H Foster, J M Zito
Journal of the American Academy of Child and Adolescent Psychiatry|June 8, 2001
Pemoline hepatotoxicity and postmarketing surveillanceD J Safer, J M Zito, J E Gardner
Pageof 31

Showing results (11-20 of 307) with videos related to

Sort By:
Pageof 31
Public Health|February 24, 2007
Do antidepressants reduce suicide rates?D J Safer, J M Zito
Foot & Ankle|October 1, 1989
Selected measures of ankle dorsiflexion range of motion: differences and intercorrelationsR W Bohannon, D Tiberio, M Zito
Frontiers in Psychiatry|April 2, 2020
Antidepressant Use in Medicaid-Insured Youth: Trends, Covariates, and Future Research NeedsJulie M Zito, Dinci Pennap, Daniel J Safer
The Journal of Orthopaedic and Sports Physical Therapy|October 6, 1997
Lasting effects of one bout of two 15-second passive stretches on ankle dorsiflexion range of motionM Zito, D Driver, C Parker, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2015
Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimensMehmet Burcu, Daniel J Safer, Julie M Zito
DICP : the Annals of Pharmacotherapy|February 1, 1990
Self-reported neuroendocrine effects of antipsychotics in women: a pilot studyJ M Zito, J B Sofair, J Jaeger
Frontiers in Psychiatry|July 1, 2021
Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and CommentaryJulie M Zito, Yue Zhu, Daniel J Safer
The American Journal of Psychiatry|July 1, 1991
New York under the Rivers decision: an epidemiologic study of drug treatment refusalJ M Zito, T J Craig, J Wanderling
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|August 19, 2000
Building pharmacoepidemiological capacity to monitor psychotropic drug use among children enrolled in MedicaidM H Fox, C H Foster, J M Zito
Journal of the American Academy of Child and Adolescent Psychiatry|June 8, 2001
Pemoline hepatotoxicity and postmarketing surveillanceD J Safer, J M Zito, J E Gardner
Pageof 31